Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Pariente
Edouard Louis

Showing results (111-120 of 364) with videos related to

Pageof 37
Sort By:
Expert Opinion on Pharmacotherapy|July 4, 2023
Stemming the tide with ileocecal Crohn's disease: when is pharmacotherapy enough?Sophie Vieujean, Paulo Gustavo Kotze, Patrick Netter, et al.
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|September 6, 2014
Endoscopic and clinical recurrences after laparoscopic or open ileocolic resection in Crohn's diseaseJustine Bellinger, Nicolas Munoz-Bongrand, Benjamin Pariente, et al.
Inflammatory Bowel Diseases|April 8, 2011
Natalizumab to kill two birds with one stone: a case of celiac disease and multiple sclerosisRémy Phan-Ba, Nadine Lambinet, Edouard Louis, et al.
Revue Medicale De Liege|February 14, 2025
[MR Imaging of ano-perineal fistulas]Paul Meunier, Catherine Reenaers, Catherine Van Kemseke, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 1, 2016
Adalimumab dose escalation is effective and well tolerated in Crohn's disease patients with secondary loss of response to adalimumabNicolas Duveau, Maria Nachury, Romain Gerard, et al.
Advances in Therapy|March 23, 2021
Quality of Life and Work Productivity Improvements with Upadacitinib: Phase 2b Evidence from Patients with Moderate to Severe Crohn's DiseaseLaurent Peyrin-Biroulet, Edouard Louis, Edward V Loftus, et al.
Inflammatory Bowel Diseases|April 12, 2023
In-Depth Assessment of Endoscopic Remission in Inflammatory Bowel Disease Treated by Anti-TNF or VedolizumabJean-Philippe Loly, Sophie Vieujean, Catherine Reenaers, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 2025
Cladribine monotherapy in a patient with coexisting Crohn's disease and multiple sclerosisSolène Dauby, Dominique Dive, Isabelle Hansen, et al.
Alimentary Pharmacology & Therapeutics|July 23, 2021
Review article: distinctions between ileal and colonic Crohn's disease: from physiology to pathologyNicolas Pierre, Catherine Salée, Sophie Vieujean, et al.
Scandinavian Journal of Gastroenterology|October 23, 2008
Sensitivity of intestinal fibroblasts to TNF-related apoptosis-inducing ligand-mediated apoptosis in Crohn's diseaseCatherine Reenaers, Nathalie Franchimont, Cecile Oury, et al.
Pageof 37

Showing results (111-120 of 364) with videos related to

Sort By:
Pageof 37
Expert Opinion on Pharmacotherapy|July 4, 2023
Stemming the tide with ileocecal Crohn's disease: when is pharmacotherapy enough?Sophie Vieujean, Paulo Gustavo Kotze, Patrick Netter, et al.
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|September 6, 2014
Endoscopic and clinical recurrences after laparoscopic or open ileocolic resection in Crohn's diseaseJustine Bellinger, Nicolas Munoz-Bongrand, Benjamin Pariente, et al.
Inflammatory Bowel Diseases|April 8, 2011
Natalizumab to kill two birds with one stone: a case of celiac disease and multiple sclerosisRémy Phan-Ba, Nadine Lambinet, Edouard Louis, et al.
Revue Medicale De Liege|February 14, 2025
[MR Imaging of ano-perineal fistulas]Paul Meunier, Catherine Reenaers, Catherine Van Kemseke, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 1, 2016
Adalimumab dose escalation is effective and well tolerated in Crohn's disease patients with secondary loss of response to adalimumabNicolas Duveau, Maria Nachury, Romain Gerard, et al.
Advances in Therapy|March 23, 2021
Quality of Life and Work Productivity Improvements with Upadacitinib: Phase 2b Evidence from Patients with Moderate to Severe Crohn's DiseaseLaurent Peyrin-Biroulet, Edouard Louis, Edward V Loftus, et al.
Inflammatory Bowel Diseases|April 12, 2023
In-Depth Assessment of Endoscopic Remission in Inflammatory Bowel Disease Treated by Anti-TNF or VedolizumabJean-Philippe Loly, Sophie Vieujean, Catherine Reenaers, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 2025
Cladribine monotherapy in a patient with coexisting Crohn's disease and multiple sclerosisSolène Dauby, Dominique Dive, Isabelle Hansen, et al.
Alimentary Pharmacology & Therapeutics|July 23, 2021
Review article: distinctions between ileal and colonic Crohn's disease: from physiology to pathologyNicolas Pierre, Catherine Salée, Sophie Vieujean, et al.
Scandinavian Journal of Gastroenterology|October 23, 2008
Sensitivity of intestinal fibroblasts to TNF-related apoptosis-inducing ligand-mediated apoptosis in Crohn's diseaseCatherine Reenaers, Nathalie Franchimont, Cecile Oury, et al.
Pageof 37